The store will not work correctly when cookies are disabled.
6-Chloro-N'-(2-hydroxy-5-methoxybenzoyl)-2-oxo-2H-chromene-3-carbohydrazide
ID: ALA4533364
PubChem CID: 145999764
Max Phase: Preclinical
Molecular Formula: C18H13ClN2O6
Molecular Weight: 388.76
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(O)c(C(=O)NNC(=O)c2cc3cc(Cl)ccc3oc2=O)c1
Standard InChI: InChI=1S/C18H13ClN2O6/c1-26-11-3-4-14(22)12(8-11)16(23)20-21-17(24)13-7-9-6-10(19)2-5-15(9)27-18(13)25/h2-8,22H,1H3,(H,20,23)(H,21,24)
Standard InChI Key: NDRKWWFVCVSGHP-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
3.3169 -3.6856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3157 -4.5051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0238 -4.9141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0220 -3.2767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7306 -3.6820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7294 -4.5072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4395 -4.9185 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1554 -4.5092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1565 -3.6840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4419 -3.2681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8619 -4.9198 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8652 -3.2772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5720 -3.6875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8672 -2.4600 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2807 -3.2806 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9874 -3.6910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6961 -3.2841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9854 -4.5081 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.3992 -3.6969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1074 -3.2907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1098 -2.4727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3981 -2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6928 -2.4710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3950 -4.5141 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.3973 -1.2453 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.1045 -0.8359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6091 -3.2772 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
8 11 2 0
9 12 1 0
12 13 1 0
12 14 2 0
13 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
19 24 1 0
22 25 1 0
25 26 1 0
1 27 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 388.76 | Molecular Weight (Monoisotopic): 388.0462 | AlogP: 2.24 | #Rotatable Bonds: 3 |
Polar Surface Area: 117.87 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.27 | CX Basic pKa: ┄ | CX LogP: 2.62 | CX LogD: 2.57 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.47 | Np Likeness Score: -0.90 |
References
1. Jesumoroti OJ, Faridoon, Mnkandhla D, Isaacs M, Hoppe HC, Klein R.. (2019) Evaluation of novel N'-(3-hydroxybenzoyl)-2-oxo-2H-chromene-3-carbohydrazide derivatives as potential HIV-1 integrase inhibitors., 10 (1): [PMID:30774857] [10.1039/C8MD00328A] |